What'sNearbyTM

What are you looking for?

Close Search
      We apologize for the inconvenience

      The people search feature on Superpages.com is temporarily unavailable. You can still search for people on yellowpages.com since Yellow Pages and Superpages are part of one company.

      You will be automatically re-directed to People Search on yellowpages.com in .

      Robert Jeffrey Kaner, M.D.

      Add to Favorites
      Be the first to review!
      Respiratory Therapists, Physicians & Surgeons, Physicians & Surgeons, Pulmonary Diseases

      425 E 61st St 11th Fl, New York, NY 10065

      646-962-2333

      CallWebsite

      REVIEWS write reviewWrite a Review

      Be the first to review!
      First-classBetter than mostAbout what I expectedNot the worst...Disappointing
      DETAILS
      General Info
      Dr. Kaner is Associate Attending Physician at the NewYork-Presbyterian Weill Cornell Medical Center and Associate Professor of Clinical Medicine and Genetic Medicine at Weill Cornell Medicine. Dr. Kaner was the Principal Investigator of the Weill-Cornell Medicine site of the NIH-sponsored Idiopathic Pulmonary Fibrosis (IPF) Clinical Research Network for which he chaired the Adjudication Committee. He has extensive experience in the phenotyping of subjects with lung disease and their enrollment in research studies. He leads a monthly multidisciplinary ILD conference with Dr. William Travis (MSKCC) and Dr. Chen Zhang (WCM) for the past 15 years. He is the director of the New York Presbyterian Hospital – Weill Cornell Medicine Pulmonary Fibrosis Foundation Clinical Center of Excellence. He participates in clinical trials evaluating various pharmacologic interventions in IPF and other ILDs, sponsored by both NIH and pharma. He leads an ILD biobank, which enhances future translational research opportunities. He leads an observational study to determine the incidence and natural history of ILD following COVID-19 acute respiratory failure.Dr. Kaner chairs the bronchoscopy sub-study committee of the NHLBI SPIROMICS and SOURCE research networks, which uses RNA-sequencing to evaluate gene expression changes in lung cells associated with smoking and COPD endotypes. He is analyzing the effects of doxycycline on BAL matrix metalloproteinase (MMP) inhibition in HIV-positive individuals with early emphysema, based on his previous translational work. He is also participating in pharmacologic intervention studies in COPD and emphysema sponsored by the ALA, DOD and NIH, including leadership (with Dr. Marshall Glesby) of a Phase II multicenter trial of doxycycline to slow emphysema progression in PLWH. He is the Associate Director of the T32 training program and Associate Fellowship Program Director.
      Categories
      Respiratory Therapists, Physicians & Surgeons, Physicians & Surgeons, Pulmonary Diseases
      Neighborhoods
      Upper East Side, Upper Manhattan
      Other Links

      https://weillcornell.org/rjkaner?utm_source=yextnetwork&utm_medium=organic&utm_campaign=yext_doctor_listings

      https://weillcornell.org/rjkaner?content=locations-and-appointments&visit=in-office&utm_source=yextnetwork&utm_medium=organic&utm_campaign=appointment_url

      Provided by
      Data provided by one or more of the following: Thryv, Data Axle, Yext.